USD
+$0.00
(+0.00%
)At Close (As of Sep 26, 2025)
$686.82M
Market Cap
51.18
P/E Ratio
1.44
EPS
$133.40
52 Week High
$67.56
52 Week Low
INDUSTRIALS
Sector
Field | Value (USD) |
---|---|
Gross Profit | $89M |
Total Revenue | $278M |
Cost Of Revenue | $189M |
Costof Goods And Services Sold | $189M |
Operating Income | $18M |
Selling General And Administrative | $38M |
Research And Development | - |
Operating Expenses | $72M |
Investment Income Net | - |
Net Interest Income | $27K |
Interest Income | $825K |
Interest Expense | $798K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $19M |
Income Before Tax | $18M |
Income Tax Expense | $3.8M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $15M |
Comprehensive Income Net Of Tax | - |
Ebit | $19M |
Ebitda | $38M |
Net Income | $15M |
Field | Value (USD) |
---|---|
Total Assets | $385M |
Total Current Assets | $78M |
Cash And Cash Equivalents At Carrying Value | $1.5M |
Cash And Short Term Investments | $1.5M |
Inventory | $14M |
Current Net Receivables | $56M |
Total Non Current Assets | $307M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $55M |
Intangible Assets Excluding Goodwill | $55M |
Goodwill | $177M |
Investments | - |
Long Term Investments | - |
Short Term Investments | $0 |
Other Current Assets | $5.7M |
Other Non Current Assets | - |
Total Liabilities | $98M |
Total Current Liabilities | $34M |
Current Accounts Payable | $17M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $5.4M |
Total Non Current Liabilities | $64M |
Capital Lease Obligations | $25M |
Long Term Debt | $31M |
Current Long Term Debt | $1.8M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $58M |
Other Current Liabilities | $11M |
Other Non Current Liabilities | $93K |
Total Shareholder Equity | $287M |
Treasury Stock | - |
Retained Earnings | $93M |
Common Stock | $4.7M |
Common Stock Shares Outstanding | $9.3M |
Field | Value (USD) |
---|---|
Operating Cashflow | $39M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $19M |
Capital Expenditures | $13M |
Change In Receivables | - |
Change In Inventory | $4.4M |
Profit Loss | - |
Cashflow From Investment | -$84M |
Cashflow From Financing | $27M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$3.6M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $15M |
Field | Value (USD) |
---|---|
Gross Profit | $89M |
Total Revenue | $278M |
Cost Of Revenue | $189M |
Costof Goods And Services Sold | $189M |
Operating Income | $18M |
Selling General And Administrative | $38M |
Research And Development | - |
Operating Expenses | $72M |
Investment Income Net | - |
Net Interest Income | $27K |
Interest Income | $825K |
Interest Expense | $798K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $19M |
Income Before Tax | $18M |
Income Tax Expense | $3.8M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $15M |
Comprehensive Income Net Of Tax | - |
Ebit | $19M |
Ebitda | $38M |
Net Income | $15M |
Sector: INDUSTRIALS
Industry: SPECIALTY BUSINESS SERVICES
Transcat, Inc. is a leading provider of laboratory instrument and calibration services, operating extensively across the United States, Canada, and internationally. Headquartered in Rochester, New York, the company serves a diverse range of industries including pharmaceutical, biotechnology, and manufacturing, ensuring compliance with stringent regulatory standards. With a commitment to quality and precision, Transcat delivers a comprehensive portfolio of services and products that enhance operational efficiency and reliability for its clients.